WB
Therapeutic Areas
Trenchant Biosystems Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AutoCell HSC Platform for SCD/beta-thalassemia | Sickle Cell Disease, beta-thalassemia | Pre-clinical |
Leadership Team at Trenchant Biosystems
PC
Philip Coelho
Chairman, Chief Technology Officer, Founder
JE
Jon Ellis
Chief Executive Officer, Founder